FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer | NEJM
Original Article from The New England Journal of Medicine — FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Related Articles
Gut Microbiota in Advanced Non-small-cell Lung Cancer Receiving Chemo-immunotherapy: An Ancillary Biomarker Study from the Phase III trial JCOG2007 (NIPPON)
Immunotherapy has transformed treatment for non-small cell lung cancer (NSCLC). However, reliable biomarkers for treatment selection remain scarce. Gut microbiota has emerged as a potential…
Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation
Breast Cancer Research and Treatment – Combination therapy has emerged as a leading trend in cancer treatment, having had a significant impact on the management…
Dr. Maryam Lustberg & Dr. Elisa Agostinetto discuss CDK4/6 inh in Breast cancer – OncoAlert
Oncology Here & NowIn this interview, Dr. Elisa Agostinetto from the Jules Bordet Institute in Belgium speaks with Dr. Maryam Lustberg from Yale Cancer Center.…
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status
PURPOSETo investigate the clinical behavior of breast cancer in young BRCA carriers according to the specific BRCA gene (BRCA1 v BRCA2) and the association of…
A virtual Experts Knowledge Share on the topic of ‘HER2 testing: The evolving role of immunohistochemistry – best practices and interpretation of results in lung…
PODCAST: Oncology Here & Now!
The top topics in oncology, delivered every 10 days by a diverse and highly specialized team of oncologists and urologists from around the world. Starting…
APCCC Diagnostics 2025 – APCCC
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid…
Cancer Facts and Statistics
Find latest information including the most current trends in cancer occurrence & survival, as well as information on prevention, early detection, & treatment.
The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!